Elevance Health, Inc. (NYSE:ELV – Free Report) – Investment analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Elevance Health in a report released on Friday, January 24th. Cantor Fitzgerald analyst S. James now anticipates that the company will earn $34.57 per share for the year, down from their prior estimate of $34.65. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.
A number of other research analysts also recently issued reports on ELV. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a report on Friday, January 17th. TD Cowen dropped their target price on Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research report on Monday, October 21st. Argus lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Finally, Barclays upped their target price on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $525.60.
Elevance Health Trading Up 0.0 %
Shares of NYSE ELV opened at $401.43 on Monday. The stock’s 50 day moving average price is $386.21 and its two-hundred day moving average price is $461.87. Elevance Health has a 52-week low of $362.21 and a 52-week high of $567.26. The stock has a market capitalization of $93.10 billion, a P/E ratio of 14.63, a PEG ratio of 1.11 and a beta of 0.84. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56.
Elevance Health (NYSE:ELV – Get Free Report) last issued its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%.
Elevance Health Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a dividend of $1.71 per share. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date is Monday, March 10th. Elevance Health’s payout ratio is presently 23.77%.
Institutional Trading of Elevance Health
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Raelipskie Partnership acquired a new position in Elevance Health in the third quarter worth approximately $26,000. PSI Advisors LLC acquired a new position in shares of Elevance Health in the 3rd quarter worth $27,000. Eastern Bank acquired a new stake in shares of Elevance Health during the third quarter worth $31,000. Crews Bank & Trust acquired a new position in shares of Elevance Health in the 4th quarter valued at $34,000. Finally, Dunhill Financial LLC increased its stake in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after purchasing an additional 26 shares in the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.
About Elevance Health
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Stories
- Five stocks we like better than Elevance Health
- Where Do I Find 52-Week Highs and Lows?
- MP Materials: Rare Earth Elements Powering the EV Boom
- What is Forex and How Does it Work?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is the NASDAQ Stock Exchange?
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.